Financials
Financial year 2025
JMedsurg from Ukkel, company number BE1014076701, closed financial year 2025 with a result of € 118,151 after tax. For that financial year JMedsurg recorded a gross margin of € 155,036 and equity of € 129,927. Compared with financial year 2024, the result moved from € 9,277 to € 118,151. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 129,927
▲ € 118,151 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 118,151
▲ € 108,874 vs 2024
Profit after tax over the fiscal year.
€ 87,277
▲ € 73,755 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 127,427.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 15,000
▼ 25% vs 2024
Loans from banks and other lenders, long and short.
€ 1,025
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 45,591
▲ 284% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 11,908 | € 155,036 | ▲ € 143,128 |
| Profit after taxes | € 9,277 | € 118,151 | ▲ € 108,874 |
| Equity | € 11,777 | € 129,927 | ▲ € 118,151 |
| Total debts | € 39,383 | € 62,273 | ▲ 58% |
| Cash | € 13,522 | € 87,277 | ▲ € 73,755 |
| Retained profit | € 9,277 | € 127,427 | ▲ € 118,151 |
| Bank debt | € 20,000 | € 15,000 | ▼ 25% |
| Balance sheet total | € 51,160 | € 192,200 | ▲ 276% |
Key figures of JMedsurg, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about JMedsurg the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to JMedsurg?
What happened at JMedsurg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 118,151 (▲ € 108,874 vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Jordan Marcelis became a director. NBB
- New establishment in Ukkel. KBO
In short
From € 9,277 profit in 2024 to € 118,151 profit in 2025.
Paid € 36,700 in corporate taxes since 2024.
Best year ever: 2025, with € 118,151 profit.
Management
Behind JMedsurg is Jordan Marcelis.
Directors
According to the 2025 annual accounts
Jordan Marcelis
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Dieweg 116
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Jordan Gustave Albert Ghislain MARCELIS(oprichter) 100%
Details
- Company number
- 1014.076.701
- VAT number
- BE 1014.076.701
- Registered office
- Dieweg 116, 1180 Ukkel
- Names & denominations
- JMedsurg
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 September 2024
- Peppol
- Active · Active since 7 Jan 2026